0.2630
-0.0100
(-3.66%)
At close: January 10 at 5:35:44 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
42.0080
372.2470
297.4420
286.4980
345.6540
Cost of Revenue
--
--
101.8270
87.0200
--
Gross Profit
--
372.2470
195.6150
199.4780
345.6540
Operating Expense
5,504.0750
6,759.4840
6,240.5430
16,509.5280
15,149.3520
Operating Income
-5,462.0670
-6,387.2370
-6,044.9280
-16,310.0500
-14,803.6980
Net Non Operating Interest Income Expense
-984.6220
-1,042.5460
-1,142.5620
-731.8650
-297.0770
Other Income Expense
-31.8610
-293.1440
-5,682.4950
-3,705.9280
-2,146.4760
Pretax Income
-6,478.5500
-7,722.9270
-12,869.9850
-20,747.8430
-17,247.2510
Tax Provision
--
--
-493.9140
-110.7390
-357.4890
Net Income Common Stockholders
-6,478.5500
-7,722.9270
-12,376.0710
-20,637.1040
-16,889.7620
Diluted NI Available to Com Stockholders
-6,478.5500
-7,722.9270
-12,376.0710
-20,637.1040
-16,889.7620
Basic EPS
-0.07
-0.08
-0.15
-0.29
-0.30
Diluted EPS
-0.07
-0.08
-0.15
-0.29
-0.30
Basic Average Shares
109,451.7640
99,322.9830
83,773.8160
70,234.8760
57,217.3560
Diluted Average Shares
109,451.7640
99,322.9830
83,773.8160
70,234.8760
57,217.3560
Total Operating Income as Reported
-5,169.9580
-6,367.3090
-5,938.7030
-16,428.9110
-14,972.1790
Rent Expense Supplemental
133.7500
123.1740
68.2910
125.7030
105.5890
Total Expenses
5,504.0750
6,759.4840
6,342.3700
16,596.5480
15,149.3520
Net Income from Continuing & Discontinued Operation
-6,478.5500
-7,722.9270
-12,376.0710
-20,637.1040
-16,889.7620
Normalized Income
-6,520.2890
-7,503.3830
-6,911.6543
-16,883.5626
-14,787.7767
Interest Expense
984.9230
1,042.5460
1,142.5620
731.8650
297.0770
Net Interest Income
-984.6220
-1,042.5460
-1,142.5620
-731.8650
-297.0770
EBIT
-5,493.6270
-6,680.3810
-11,727.4230
-20,015.9780
-16,950.1740
EBITDA
-5,381.6240
-6,484.6180
-11,511.8210
-19,192.7630
-16,053.7040
Reconciled Cost of Revenue
--
--
101.8270
87.0200
--
Reconciled Depreciation
112.0030
195.7630
215.6020
823.2150
896.4700
Net Income from Continuing Operation Net Minority Interest
-6,478.5500
-7,722.9270
-12,376.0710
-20,637.1040
-16,889.7620
Total Unusual Items Excluding Goodwill
41.7390
-219.5440
-5,682.4950
-3,773.6830
-2,146.4760
Total Unusual Items
41.7390
-219.5440
-5,682.4950
-3,773.6830
-2,146.4760
Normalized EBITDA
-5,423.3630
-6,265.0740
-5,829.3260
-15,419.0800
-13,907.2280
Tax Rate for Calcs
--
--
0.0000
0.0000
0.0000
Tax Effect of Unusual Items
--
--
-218.0783
-20.1416
-44.4907
12/31/2020 - 5/29/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
H6D0.DE Haleon plc
4.4650
-3.12%
HIGH.DE Cantourage Group SE
4.8200
0.00%
ZOE.DE Zoetis Inc.
160.64
+0.59%
B8FK.DE Biofrontera AG
2.2700
0.00%
27N0.DE CANNOVUM CANNABIS AG I
0.5300
+0.95%
VIA.DE Viatris Inc.
11.36
-1.65%
APPH.DE Apontis Pharma AG
10.20
+0.99%
PSG.DE PharmaSGP Holding SE
26.80
+0.75%
2HQ.DE Tilray Brands, Inc.
1.1715
-10.26%
DMP.DE Dermapharm Holding SE
40.05
+0.63%